Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04298541 · ClinicalTrials.gov registry record · Phase 2
Direct Comparison of Ga-68-DOTATATE and Ga-68-DOTATOC
A Phase 2 study, sponsored by Weill Medical College of Cornell University.
- Not yet
- Registry status
- Phase 2
- Development phase
- 6
- Enrollment target
NCT04298541 is a Phase 2 study that has not yet begun recruiting, run by Weill Medical College of Cornell University. The registered enrollment target is 6 participants.
The verdict
NCT04298541, a Phase 2 study, has not yet begun recruiting, sponsored by Weill Medical College of Cornell University.
- NOT YET RECRUITING
- Registry status
- Phase 2
- Development phase
- 6 participants
- Enrollment target
Study Summary
The goal of this study is to propose the first direct comparison of Ga-68-DOTATATE PET/CT or PET/MR and Ga-68-DOTATOC PET/CT in patients with meningioma.
Interventions
- DRUG Ga-68- DOTATATE
- DRUG Ga-68-DOTATOC
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2026-06 |
| Est. Completion | 2027-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04298541
The ClinicalTrials.gov registry entry for NCT04298541 describes a study currently listed as not yet recruiting, categorized as Phase 2. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Ga-68- DOTATATE is the first listed.
NCT04298541 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04298541 about?
NCT04298541 is a clinical study titled "Direct Comparison of Ga-68-DOTATATE and Ga-68-DOTATOC". The goal of this study is to propose the first direct comparison of Ga-68-DOTATATE PET/CT or PET/MR and Ga-68-DOTATOC PET/CT in patients with meningioma.
What is the current status of trial NCT04298541?
This trial is currently not yet recruiting. It is a Phase 2 study. The enrollment target is 6 participants. The study started on 2026-06. Estimated completion is 2027-06.
What interventions are being tested in trial NCT04298541?
The interventions under investigation include: Ga-68- DOTATATE (DRUG), Ga-68-DOTATOC (DRUG).
Who is sponsoring clinical trial NCT04298541?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.